School of Pharmacy

R. William Soller, PhD, executive director, UCSF School of Pharmacy Center for Consumer Self Care, is the co-recipient of the Golden Thinker Award from the North American Precis Syndicate (NAPS).

Guglielmo named new department of clinical pharmacy chair. New faculty members: Boyd, Burchard, Cutler, Lee, MacDougall, Nkansah, Orrico, Tang, and Wells. Parfitt Pattie now oversees alumni relations in addition to fundraising. Research highlights. Honors and awards: Langridge, Giacomini, Herfindal...

B. Joseph Guglielmo Jr., PharmD, has been named chair of the department of clinical pharmacy, School of Pharmacy, University of California, San Francisco. The appointment is effective March 20, 2006.

Marilyn Stebbins, PharmD, UCSF School of Pharmacy clinical professor and drug benefit expert, explains the problems as of January 2006 with the rollout of the Medicare Part D drug benefit. She advises seniors on how to get the medication coverage that best meets their needs.

A new public board is needed to standardize, measure, and ultimately improve the quality of health care in the United States, according to UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, and University of California colleagues Stephen M. Shortell, PhD, MPH, and Steven A.

Reports to the California Poison Control System of the use of the drug gamma hydroxybutate (GHB) have declined overall from 1999 to 2003. These findings were reported on December 29, 2005 in the Annals of Emergency Medicine.

Robert D. Gibson, PharmD, UCSF School of Pharmacy alumnus and former associate dean, is the 2006 recipient of the Remington Honor Medal. This is the highest honor bestowed by the American Pharmacists Association (APhA).

Through better understanding of where and how the brain gets, or "traffics," fresh supplies of particular receptors needed to carry chemical signals between nerve cells, researchers hope to better understand how we learn, remember, and possibly forget.

The 2005 potential avian flu pandemic caused a shortage of antiviral drugs, leading to concerns about access, efficacy, and distribution.